Trinity Biotech (TRIB) Expected to Announce Quarterly Earnings on Wednesday

Trinity Biotech (NASDAQ:TRIB) is expected to issue its quarterly earnings data before the market opens on Wednesday, January 29th. Analysts expect the company to announce earnings of ($0.54) per share for the quarter.

Trinity Biotech Stock Down 2.5 %

Shares of TRIB stock opened at $0.81 on Wednesday. The business has a 50-day moving average price of $1.00 and a two-hundred day moving average price of $1.69. Trinity Biotech has a 12-month low of $0.75 and a 12-month high of $3.55. The firm has a market cap of $6.30 million, a P/E ratio of -0.36 and a beta of 1.01.

Trinity Biotech Company Profile

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.